All In MedTech

FDA Clearance Tracker · P220002

TOPS™ System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Jun 15, 2023 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product codeBreakthrough

Decided

Jun 15, 2023

Approved

Time to decision

484 days

Received Feb 16, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P220002
Device name
TOPS™ System
Applicant location
Netanya
Received
Feb 16, 2022
Decided
Jun 15, 2023
Decision
Approved
Supplements
11 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QWK

FDA's approval statement

As written in FDA's record.

Approval for The TOPS System is a motion-preserving spinal implant that is inserted into the lumbar spine via pedicle screws. The TOPS System is intended to stabilize the spine following a lumbar decompression without rigid fixation.The TOPS System is indicated for patients between 35 and 80 years of age with symptomatic degenerative spondylolisthesis up to Grade I, with moderate to severe lumbar spinal stenosis and either the thickening of the ligamentum flavum and/or of the scarring facet joint capsule at one level from L3 to L5.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QWK (Prosthesis, posterior spinal elements).
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

Other decisions for Premia Spine, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.